Eden Research plc

August 01, 2008 10:41 ET

Director Shareholding

Eden Research plc
1 August 2008

                         Eden Research plc ("Eden Research" or the "Company")
                                 Correction - Directors' Shareholdings

On 11 July 2008, Eden Research issued two announcements regarding the shareholdings of Stephen O'Brien
and Sir Ben Gill, both non-executive directors of the Company.

It was stated that Stephen O'Brien holds 47,059 shares representing 0.8% of the Company's issued share
capital and Sir Ben Gill holds 39,603 shares, representing 0.7% of the Company's share capital.  The
percentages were incorrectly calculated and the correct percentages are as set out below:

Director                           Total shares held                  Percentage of issued share
Stephen O'Brien                    47,059                             0.08%
Sir Ben Gill                       39,603                             0.07%

Eden Research has 56,313,274 ordinary shares in issue.

For further information, please contact:

Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844

Jonathon Brill/Caroline Stewart, Financial Dynamics
T: 020 7831 3113

About Eden Research plc

Eden  Research plc is a UK publicly listed company on the PLUS Market, specialising in the development
of agrochemical products and intellectual property through licensing and marketing agreements.

Eden  is focused on developing products for the agricultural sector through the application of terpene
chemistry  and  other  patented  environmentally friendly technologies.   Eden  is  currently  working
alongside   universities   and  partner  companies  in  developing  its  product   portfolio   towards

For further information please visit www.edenresearch.com.

Contact Information

  • Eden Research plc